Back to top
HOW UDENYCa® (pegfilgrastim-cbqv) WORKS
HOW UDENYCA® (Pegfilgrastim-cbqv) WORKS
How chemotherapy affects your white blood cells
Chemotherapy treatment can help stop cancer cells from growing, but it can also lower your white blood cell count. White blood cells are a vital part of your immune system and help your body fight infection.
What is febrile neutropenia?
A low white blood cell count can put you at risk for infection and a serious complication called febrile neutropenia. Febrile neutropenia is when your white blood cell counts are extremely low and paired with a fever. This may be a sign of infection or other serious illness, which can delay your next round of chemotherapy.
Call your healthcare team immediately if you experience a fever greater than or equal to 100.4° Fahrenheit (38.0° Celsius).
UDENYCA may help support your immune system while undergoing chemotherapy
Take UDENYCA as prescribed to help reduce your risk of febrile neutropenia and stay on track with your chemo regimen
UDENYCA is administered the day after chemotherapy and is usually prescribed with every chemotherapy cycle.
For example, if you have 6 cycles of chemotherapy, you may receive 6 doses of UDENYCA.
There are 3 ways to take UDENYCA
UDENYCA Solutions™, part of the Coherus Solutions™ family of patient support services, offers a range of programs and financial assistance.
See which administration option fits into your life
What is UDENYCA?
UDENYCA is a prescription medicine used to help reduce the chance of infection due to a low white blood cell count, in people with certain types of cancer (non-myeloid), who receive anti-cancer medicines (chemotherapy) that can cause fever and low blood cell count.
UDENYCA is a type of biologic treatment called a biosimilar
Biologics are a type of medicine made from living cells. They are often used to treat diseases such as cancer, immune system disorders, and diabetes. A vaccine is an example of a biologic you may be familiar with.
A biosimilar is a product made to be highly similar to another biologic. It is made to be as safe and effective as the original biologic.
Reference biologic
  • Made from a living system
  • Made of thousands of parts
  • Cannot be replicated exactly the same every time
  • Highly similar to the reference biologic product, which may have minor differences
  • No clinically meaningful differences in terms of the safety, purity, and potency
UDENYCA is a biosimilar of the medication Neulasta® (pegfilgrastim).
Common side effects of UDENYCA
The most common side effects of UDENYCA are pain in the bones, arms, and legs.
These are not all the possible side effects of UDENYCA. Please see the Important Safety Information and call your doctor for medical advice about these and other side effects. You may report side effects to Coherus BioSciences at 1-800-4-UDENYCA (1-800-483-3692) or notify the FDA at 1-800-FDA-1088.
Additional UDENYCA resources are available
Find answers to frequently asked questions about UDENYCA and resources to help you learn more about your treatment.
See the resources